ISO 13485 Clause 8.2.6 Monitoring and Measurement of Product Explained (2026 Guide)

ISO 13485 Clause 8.2.6 Monitoring and Measurement of Product Explained (2026 Guide)

ISO 13485 Clause 8.2.6 requires medical device companies to monitor and measure product characteristics at defined stages to verify that product requirements are met. Evidence must be recorded, and product cannot be released until all acceptance criteria are satisfied.

If you cannot prove your product meets requirements before release, you are noncompliant.


What Clause 8.2.6 Actually Requires

Clause 8.2.6 ensures that your product is verified against defined specifications before it reaches the customer.

This includes:

  • Inspection
  • Testing
  • Verification activities

The key requirement is simple: you must demonstrate conformity with objective evidence.


Where Monitoring and Measurement Happens

Monitoring and measurement can occur at multiple stages:

  • Incoming inspection (raw materials, components)
  • In-process inspection (during manufacturing)
  • Final product verification (before release)

Critical point: The stage depends on where conformity can be effectively verified.


Key Requirements of Clause 8.2.6

1. Defined Acceptance Criteria

You must clearly define what “acceptable” looks like:

  • Specifications
  • Tolerances
  • Functional requirements

Audit risk: Vague or undefined criteria.


2. Documented Evidence

You must maintain records showing:

  • What was measured
  • How it was measured
  • Results obtained
  • Who performed the activity

If it is not recorded, it did not happen.


3. Traceability to Product

Records must link directly to:

  • Product batch or serial number
  • Device history record (DHR)

4. Product Release Control

Products cannot be released until:

  • All required inspections are completed
  • Results meet acceptance criteria

Exception: Release under concession must be justified and documented.


Real Audit Findings for Clause 8.2.6

Finding 1: Missing Inspection Records

Issue: No evidence that product was verified before release.

Fix:

  • Define mandatory inspection points
  • Implement controlled templates
  • Audit record completeness regularly

Finding 2: Acceptance Criteria Not Defined

Issue: Product checked, but no clear pass/fail criteria.

Fix:

  • Define measurable acceptance criteria
  • Link to design inputs and specifications

Finding 3: Product Released Without Full Verification

Issue: Release performed before all tests completed.

Fix:

  • Implement release checklist
  • Require sign-off based on complete evidence

Finding 4: Poor Traceability

Issue: Inspection records not linked to product.

Fix:

  • Link records to batch/serial numbers
  • Ensure full traceability in DHR

How Clause 8.2.6 Links to Design Controls

Monitoring and measurement must align with design requirements.

This means:

  • Inspection criteria must come from design inputs and outputs
  • Verification activities must confirm design requirements are met

Related:


How Clause 8.2.6 Links to Risk Management

Product monitoring supports risk control.

Critical characteristics identified in risk analysis must be:

  • Monitored
  • Measured
  • Controlled

Related:


How to Build a Strong Product Monitoring System

Step 1: Define Critical Product Characteristics

  • Dimensions
  • Performance
  • Safety-related features

Step 2: Define Inspection Points

  • Incoming
  • In-process
  • Final release

Step 3: Standardise Measurement Methods

  • Calibrated equipment
  • Validated methods

Step 4: Control Records

  • Use structured templates
  • Ensure traceability

Step 5: Control Release

  • Define release authority
  • Require complete evidence before approval

Common Mistakes to Avoid

  • Relying on informal inspection practices
  • Not defining measurable criteria
  • Releasing product before verification is complete
  • Poor record traceability

These are frequent audit findings.


Quick Audit Checklist for Clause 8.2.6

  • Are acceptance criteria clearly defined?
  • Are inspection records complete and traceable?
  • Is product release controlled and documented?
  • Are measurements reliable and consistent?

If any answer is no, your system is exposed.


When to Strengthen Your System

You should take action if:

  • You have product-related audit findings
  • Inspection records are inconsistent
  • Release decisions are unclear
  • You are scaling production

Next steps:


Final Thought

Clause 8.2.6 is where product quality becomes real.

You are no longer defining systems—you are proving that your product meets requirements.

If you cannot demonstrate conformity with evidence, your system will not pass audit scrutiny.

Back to blog

Leave a comment

About ISO Cloud Consulting

Structured, regulator-aligned guidance for medical-device teams building ISO 13485 systems, MDR/FDA documentation, PMS/Vigilance frameworks, and validated digital QMS environments.

Ultra-clean white–blue regulatory workspace with structured binders labeled Document Control, Risk Management, Supplier Lifecycle, Training & Competence. Faint ISO 13485 documents layered in background. Crisp clinical lighting, no people.

Need a Fully Structured, Audit-Ready QMS?

Implement ISO 13485, MDR, FDA QMSR, and complete documentation systems with validated workflows and regulator-aligned templates.

Contact Us Today